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responsibility of XAbstract As part of the method development, the injection volume as a critical quality attribute in
fast fused-core chromatography was evaluated. Spilanthol, a pharmaceutically interesting N-
alkylamide currently under investigation in our laboratory, was chosen as the model compound.
Spilanthol was dissolved in both PBS and MeOH/H2O (70/30, v/v) and subsequently analyzed
using a fused-core system hereby selecting ﬁve chromatographic characteristics (retention time,
area, height, theoretical plates and symmetry factor) as responses. We demonstrated that the
injection volume signiﬁcantly inﬂuenced both the qualitative and quantitative performance of
fused-core chromatography, a phenomenon which is confounded with the nature of the used
sample solvent. From 2 mL up to 100 mL injection volume with PBS as solvent, the symmetry factor
decreased favorably by 20%. Moreover, the theoretical plates and the quantitative parameters (area
and height) increased up to 30%. On the contrary, in this injection volume range, the theoretical
plates for the methanol-based samples decreased by more than 60%, while the symmetry factor
increased and the height decreased, both by 30%. The injection volume is thus a critical and often
overlooked parameter in fused-core method description and validation.
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i’an Jiaotong University.1. Introduction
The demand for high-throughput high performance liquid
chromatography (HPLC) systems is ever-growing and rapid
low-cost analyses for drug screening and discovery, drug
development and quality control become more desirable.
Therefore, newly developed fused-core HPLC stationarylsevier B.V. All rights reserved.
Injection volume in fused-core chromatography 331phases such as HALOs columns have attracted the interest of
the chromatographic community [1–3]. Due to their small
particle size (2.7 mm) and unique particle technology with a
0.5 mm porous superﬁcial shell fused to a solid inert core
(1.7 mm), these columns allow for fast and high-performance
separations when compared to the conventional, fully porous,
packed columns [4–7].
Like sub-2-mm ultra high performance liquid chromatogra-
phy (UHPLC) particles, fused-core columns generate ﬂatter
van Deemter curves, with the additional advantage of lower
back pressure [8]. Consequently, higher ﬂow rates, resulting in
faster LC separations with almost no signiﬁcant loss in
chromatographic performance, can be used [9,10]. Although
the separation efﬁciency is generally somewhat lower than
those of sub-2-mm UPLC columns, conventional standard
HPLC equipment can be used with fused-core columns [11].
However, using the conventional HPLC equipment, several
extra-column operational aspects are becoming critical in
fused-core chromatography. Extra-column dispersion (ECD)
is mainly affected by extra-column volumes (ECV), which is
expressed by four additive sources: the injection volume, the
volume of the pre- and post-column connecting tube, detector
ﬂow cell and signal processing electronics (like detector time
and sample rate) [1]. Alexander et al. [1] investigated the
inﬂuence of aforementioned volumetric parameters exten-
sively, except for the injection volume.
We hypothesize that due to ECV, developmental para-
meters like the injection volume are also becoming more
pronounced in fused-core compared to conventional HPLC
chromatography and should not be neglected. Therefore, we
have concentrated on the effects of altering the injection
volume using fused-core chromatography on conventional
HPLC equipment and standard HPLC operational settings.
The pharmaceutically interesting plant bioactive spilanthol
was chosen as the model compound, as this N-alkylamide is
included in one of our laboratory research topics [12,13].
To demonstrate the applicability of the injection volume
optimized fused-core HPLC method, the transdermal behavior
of spilanthol in hydroxypropyl methyl cellulose (HPMC)-
based patches containing different percentages of plasticizer
triethyl citrate (TEC) (5% and 20%, m/m) and penetration
enhancer oleic acid (OA) (0 and 5%, m/m) was investigated
using human skin in a Franz diffusion cell (FDC) set-up.2. Materials and methods
2.1. Reagents
For fused-core HPLC method optimization, A. Vogel Spilanthes,
containing 0.1% (m/m) spilanthol, was a generous gift from
Bioforce (Roggwil, Switzerland). Spilanthol containing patches
were manufactured using Jambu Ole´ore´sine 30% (m/m) spilanthol
in ethanol (Robertet, Grasse, France), which was evaporated to
give a concentration of 67% (m/m) spilanthol. HPLC gradient
grade methanol (MeOH) and acetonitrile (ACN) were supplied by
Fisher Scientiﬁc (Leicestershire, UK). Pro-analysis formic acid was
purchased from Acros Organics (Geel, Belgium). Water was
puriﬁed using an Arium 611 puriﬁcation system (Sartorius,
Go¨ttingen, Germany), resulting in ultrapure water of 18.2 MO cm
quality. Phosphate buffered saline (PBS) (pH 7.4; 0.01 M) came
from Sigma (St. Louis, MO, USA). Hydroxypropyl-b-cyclodextrin(HPbCD) was supplied by Cerestar (Sas van Gent, Netherlands).
Chloroform was bought from VWR (Haasrode, Belgium), while
dichloromethane and oleic acid (OA) came from Fluka (Stein-
heim, Germany). Hydroxypropyl methyl cellulose (methocel K4M
premium) was kindly provided by Colorcon (Kent, England).
Triethyl citrate (TEC) was obtained from Aldrich (Steinheim,
Germany).
2.2. Method description
A superﬁcially porous HALOs RP-amide column (4.6 mm 
50 mm, 2.7 mm particle size, 90 A˚ pore size, and 150 m2/g
speciﬁc surface area), protected by an RP-amide guard column
(4.6 mm  5 mm, 2.7 mm particle size) (both from Advanced
Material Technology, Wilmington, DE, USA) was used.
According to the quality assurance report of the manufac-
turer, the minimal number of theoretical plates (Ncol) is 10,000.
From the t0 of uracil (0.2 min) at a ﬂow rate of 1.8 mL/min,
the void volume (Vcol) is calculated to be 0.360 mL.
A newly purchased column and aged column (i.e., having
approximately 1000 injections with similar matrices) were used
with a degassed isocratic mobile phase, consisting of 0.1% or
1% (v/v) formic acid in MeOH/H2O (70/30, v/v) or 1% (v/v)
formic acid in ACN/H2O (60/40, v/v). The ﬂow rate was set at
1.5 mL/min. UV detection was performed at 237 nm. Dilu-
tions of the A. Vogel Spilanthes extract in PBS as well as in
70/30 (v/v) MeOH/H2O were made to accommodate injection
volumes ranging from 2 to 100 mL, while maintaining con-
sistent mass loads (0.499 mg). For each condition, triplicate
injections were made. The ﬁve chromatographic characteristics
(retention time, height, area, theoretical plates and symmetry
factor) were calculated in accordance with the European
Pharmacopoeia: the theoretical plates (N) were determined
from peak widths at half height and the symmetry factor (As)
was calculated at one-twentieth of the peak height from the
ratio of the whole width and two times the distance between
the peak maximum and leading edge of the peak [14].
2.3. HPLC instrumentation
The HPLC apparatus consisted of a Waters Alliance 2695
separation module equipped with an autosample injector and a
Waters 2996 PDA controlled by Empower 2 software (all Waters,
Millford, USA). Injection accuracy has been stated by the supplier
as72% (50 mL, n¼6) with a range of 0.1–100 mL. The standard
instrumental conﬁgurations for conventional HPLC were used
without further optimization. Connective pre-column tubing (from
auto-injector valve outlet to column inlet) consisted of a 135 mm
(0.3 mm i.d.) stainless steel tubing and a 460 mm (0.25 mm i.d.)
peek tubing. For post-column (from column outlet to ﬂow cell
inlet), a 400 mm (0.12 mm i.d.) peek tubing was used. The detector
cell volume was 9.3 mL. Considering the dimensions of the RP-
amide fused-core column and the capacity factor k0 for the
described method (k0 ¼5), the maximum acceptable detector cell
volume (Vcell) [1] is not exceeded and thus appropriate:
Vcellr
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
0:2V2colð1þ k0Þ2
Ncol
s
¼ 93:3mL
The equations on maximum acceptable detector time con-
stant (t) and minimum detector sampling rate [1] were used as
J. Boonen et al.332a guidance for detector conﬁgurations.
tr
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% band spreading
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ð1þ kÞVolcol=Fﬃﬃﬃﬃﬃﬃﬃﬃﬃ
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If maximal band spreading of 5% is considered, using the
4.6 mm  50 mm RP-amide fused-core column with a ﬂow rate
F of 1.5 mL/min, the time constant t should be equal to or smaller
than 0.2 s. A detector time constant of 0.2 s was selected.
Detector sample rateZ
5F
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Nobs
p
Vcolð1þ kÞ
¼ 5:5Hz
Considering a maximal 10% overall loss in efﬁciency due to
extra-column band broadening (i.e., Nobs¼0.9Ncol) and the
column and method parameters as mentioned above, the required
detector sampling rate should beZ5.5 Hz. Although the standard
setting of 10 Hz for conventional separations is still relatively low
for fused-core chromatography, this frequency is typically used in
conventional HPLC and hence was applied in our experiments.20
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Fig. 1 Chromatographic characteristics of PBS (A) and metha-
nol-based (B) samples expressed as percentage relatively to the
injection volume of 2 mL (¼100%). Conditions: 0.1% formic acid
in MeOH/H2O (70/30, v/v) mobile phase composition on aged
column.2.4. Franz diffusion cell experiments using human skin
The target concentration of the HPMC-based patches was 8%
(m/m) spilanthol per dry weight. Appropriate amounts of
concentrated Jambu extract, HPMC, TEC and OA were
dissolved in a 10 mL chloroform:methanol:dichloromethane
(4:4:2, v/v/v) mixture to obtain four different HPMC patches,
containing 5%TEC/ 0%OA, 5%TEC/ 5%OA, 20%TEC/
0%OA and 20%TEC/ 5%OA (m/m), respectively. The
obtained solutions were shaken vigorously and poured on
silicone paper. After solvent-evaporation overnight, patches
were stored in a desiccator for one day. Before transdermal
application, the patches were punched (diameter¼0.95 cm),
weighed and their thickness (3271.2 mm, mean7SEM, n¼36)
was determined using a micrometer (Heidenhain, Schaum-
burg, USA). The permeation of spilanthol through human
skin was determined using static Franz diffusion cells (FCDs)
as described elsewhere [12,13]. The thickness of the skin,
obtained from two female patients (55 and 77 years old),
was measured to be 39579 mm (mean7SEM, n¼65).
The receptor chamber was ﬁlled with a 0.01 M PBS solution
containing 0.5% HPbCD. Next, the patches were brought
on the epidermal surface of the skin. To ensure optimal
contact between the patch and the skin, paraﬁlm (American
National CanTM, Chicago, USA) was spanned over the patch.
Subsequently, the dose chamber was placed on top of the
paraﬁlm and the whole set-up was held together with a clamp.
Franz diffusion cell samples of the receptor ﬂuid (200 mL) were
drawn at regular time intervals from the sample port (1, 2, 5,
8, 12, 20 and 24 h) and the receptor chamber was immediately
replenished with 200 mL fresh solution. The spilanthol content in
the samples was assayed using the optimized high-throughput
fused-core HPLC-UV method (100 mL injection volume and
0.1% FA (v/v) in 70/30 MeOH/H2O (v/v) mobile phase).
At the end of the experiment (i.e., after 24 h), the mass balance
was constructed and the overall percentage spilanthol recovered
was 100.0872.62% (mean7SEM, n¼33). The skin permeation
parameters were calculated from the plot of cumulative amount
of spilanthol permeated through the skin as a function of
time [12,13].3. Results and discussion
For proﬁling purposes of N-alkylamides, fully porous columns
are traditionally used [12]. Moreover, these columns have also
been applied in high-throughput systems for the isobutylamide
spilanthol [13]. However, compared to fused-core based high-
throughput systems, the total run time of conventional column
based systems is more than doubled, making this new core–
shell technology very interesting when analyzing large sample
amounts.
Besides the commonly used C18 fused-core columns, where
separation efﬁciency under different conditions was investi-
gated for a wide variety of chemical components [11,15–20],
other fused-core columns such as C8, HILIC, RP-amide,
peptide, phenyl-hexyl are becoming available. In contrast to
C18 fused-core columns, little investigation has been carried
out on the column performance of these other stationary
phases [21–23]. Therefore, we selected the newly available RP-
amide stationary phase, for which at this time no quality
parameters have been investigated.
Injection volume in fused-core chromatography 333The effect of the injection volume on the performance of
RP-amide fused-core HPLC chromatography has been estab-
lished and demonstrated to be more pronounced than on
conventional columns. Varying the injection volume within
the 2–100 mL range results in altered performance character-
istics. Detailed information about the chromatographic char-
acteristics are presented in Supplementary Table 1, and results
were depicted, relative to the 2 mL injection volume, in Fig. 1.
Moreover, typical chromatograms are shown in Fig. 2. The
ECV, which is negligible in conventional chromatography,
causes signiﬁcant ECD for fast fused-core columns. The ECD
is generally more pronounced with increasing injection
volume. Comparing Fig. 1A (PBS sample solvent) with 1B
(MeOH/H2O, 70/30, v/v sample solvent), it is clear that the
inﬂuence of the injection volume is confounded with the
sample solvent. Using the MeOH based sample solvent
(Fig. 1B), a linear loss of peak performance is observed in
the higher injection volume range (25–100 mL) with a decrease
in theoretical plates (N) up to 60% and an increase in symmetry
factor (As) with 30% (2–100 mL). This collapse in efﬁciency wasAU
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Fig. 2 Typical chromatograms demonstrating the effect of
injection volume for PBS and MeOH/H2O (70/30, v/v) as sample
solvent. Conditions: 0.1% formic acid in MeOH/H2O (70/30, v/v)
mobile phase composition on aged column.
Table 1 Mean transdermal parameters for spilanthol in four dif
Transdermal parameters Patch composition (%TEC/7OA)
5% TEC/OAa 5% TEC
Observed secondary parameters
Jss (mg/cm
2/h) 0.50760.08 0.52744
Q1d (% dose applied) 8.99772.15 7.61753
Lag time (h) 6.22730.15 5.64740
Apparent primary parameters
Kp (10
6 cm/h) 4.91762.26 5.11748
Dm (10
5 cm2/h) 4.51728.70 5.87764
Km (10
3) 4.56767.60 4.55757
an¼10.
bn¼9.
cn¼7.not seen when using PBS as sample solvent. Between 25 and
100 mL injection volume, the chromatographic characteristics
remain constant. This can be explained by the relatively weaker
solvent strength of PBS, resulting in on-column band compres-
sion, whereby solute molecules concentrate at the head of the
column [24]. By increasing injection volumes from 2 to 25–
100 mL, chromatographic parameters favorably alter, yielding a
decrease of 20% in the symmetry factor and an increase of the
theoretical plates with 30%. A striking observation is the effect
at very low injection volumes, which was not further elaborated
at this stage. However, all these observations clearly indicate
that the injection volume is a critical quality parameter (i.e. a
critical quality attribute (CQA)) for qualitative as well as
quantitative fused-core based chromatography.
On the contrary, other investigated factors have a limited
contribution to the chromatographic characteristics: no major
effects between the investigated mobile phases have been observed
and the column age minimally affects the performance, demon-
strating the ruggedness and stability of those systems.
Higher injection volumes inherently yield a higher sensitivity.
To cope with low concentrated samples generated from e.g.
biomedical assays like Franz diffusion cells, 100 mL aqueous
samples are preferably introduced on the HALOs RP-amide
column. At this high injection volume, the LOD for spilanthol
decreased with a factor of 35, from 5.95 mg/mL (for 2 mL
injection volume) to 0.17 mg/mL (for 100 mL injection volume).
The analytical veriﬁcation of this high-throughput LC-UV
method assured linearity (e.g., R2¼0.999) in a working range
of 0.57 mg/mL (LOQ) up to 10 mg/mL, with a repeatability of
1.21% (n¼3).
Using the FDC ﬂux curves (see Supplementary Fig. S1), the
transdermal parameters could be calculated (see Table 1).
Neither the plasticizer percentage TEC nor the presence of OA
penetration enhancer had an inﬂuence on the skin permeation
of spilanthol. The spilanthol concentration in the skin (epi-
dermis plus dermis) ranged between 9.815 103 ng/mL and
1.889 105 ng/mL. At these concentrations local immune
effects are certainly to be expected in the skin [15]. Moreover,
systemic effects after dermal application are plausible: the
steady-state plasma concentration after a 24 h dermal applica-
tion of a 20% TEC/ 0% OA patch with a surface of 10 cm2
was calculated to be 4.58 102 ng/mL. This is a functional
plasma level, resulting in immune-modulatory effects [15].ferent patches [mean7RSD (%)].
/þOAb 20% TEC/OAc 20% TEC/þOAc
.88 0.64712.72 0.43722.50
.29 9.1478.97 5.92727.89
.28 5.22727.59 6.70719.32
.35 5.7977.92 4.34722.82
.53 5.34730.08 5.00719.01
.50 4.64731.54 4.50736.59
J. Boonen et al.3344. Conclusions
In contrast to the classic, fully porous HPLC columns, extra-
column parameters demand special attention when fused-core
columns are used with conventional HPLC equipment. Not only
do the instrument conﬁguration settings contribute to the peak
performance, but also the injection volume is more critical than
generally thought. Qualitative and quantitative chromatographic
characteristics can vary signiﬁcantly as a function of the injection
volume, which in turn can be confounded with the sample
solvent. Both the injection volume, the sample solvent and the
instrument conﬁguration settings are thus analytical CQAs which
should be well deﬁned in method development and validation,
and not be overlooked in method transfer. On the contrary, the
mobile phase composition and column age do not have a
signiﬁcant inﬂuence on the chromatographic characteristics in
our operational conditions.
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